One Approach to Constructing a Meningococcal A/B/C Vaccine

Carl Frasch, Food and Drug Administration

3:15

Discussion

4:00

Break

4:15

Summary and Synthesis: Day 1

Moderators

4:45

Adjourn

Day 2

8:30

Continental Breakfast

9:00

Proving Vaccine Efficacy: The Challenge of Developing-Country Field Trials

Moderator: George Siber, Massachusetts Department of Health

Pneumonia Diagnostics: The Achilles Heel of ARI Epidemiology

Claire Broome, Centers for Disease Control and Prevention

The Case-Control Method and Other Alternative Design Strategies

Helena Makela, National Public Health Institute, Helsinki, Finland

Report of a Post-Licensure Hib Efficacy Trial in Chile

Myron Levine, University of Maryland

9:45

Discussion

10:45

Break

11:00

The Public-/Private-Sector Interface

Moderator: William Hubbard, Steering Committee Member

  • An Industry Perspective

    Peter Paradiso/Frank Malinoski, Lederle-Praxis Biologicals



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement